Login   |  
Contact   |  

Pharma patentees toast EPO win but clinical trial risks remain

An EPO Board of Appeal ruling on how patentees can avoid disclosing prior art from clinical trials is welcome, but issues remain for future spats, counsel say

View Full Article

Related Articles

News Feed

Cancelling a Patent Claim

by Dennis Crouch The pending case of Jump Rope Systems v. Coulter Ventures is fascinating to me as someone who…
Learn More
News Feed

Just before Ericsson v. Apple ITC trial, PTAB institutes IPR of patent-in-suit, and Apple walked back on promise not to rely on same prior art in ITC case

Sooner or later Ericsson and Apple will have to settle their patent dispute, but as long as they are litigating,…
Learn More
News Feed

HubSpot IP counsel plans to give merch for patents

Inspired by his former team at Pure Storage, Suvashis Bhattacharya wants to reward inventors with merchandise, he tells Managing IP…
Learn More
Generated by Feedzy